Related Experiment Videos
Cutaneous larva migrans--a traveller's disease.
1Tairawhiti Area Health Board, Gisborne Hospital.
The New Zealand Medical Journal
|July 25, 1990
Summary
A traveler returning from Malaysia developed cutaneous larva migrans. This skin infection was effectively treated with the antiparasitic medication mebendazole.
Area of Science:
- Medical Parasitology
- Dermatology
- Tropical Medicine
Background:
- Cutaneous larva migrans (CLM) is a human parasitic infection caused by the larval forms of hookworms, primarily Ancylostoma species.
- It is commonly acquired through contact with soil or sand contaminated with infected larvae, often in tropical and subtropical regions.
Observation:
- A case report details a New Zealander who presented with symptoms suggestive of CLM after a recent trip to Malaysia.
- The patient exhibited characteristic skin lesions consistent with CLM.
Findings:
- The diagnosis of cutaneous larva migrans was confirmed in the patient.
- Successful treatment was achieved using mebendazole, an anthelmintic medication.
Implications:
- This case highlights the importance of considering CLM in travelers returning from endemic areas.
- Mebendazole demonstrates efficacy in treating cutaneous larva migrans, offering a viable therapeutic option.